These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 1316233)
1. Selective mutation of codons 204 and 213 of the p53 gene in rat tumors induced by alkylating N-nitroso compounds. Ohgaki H; Hard GC; Hirota N; Maekawa A; Takahashi M; Kleihues P Cancer Res; 1992 May; 52(10):2995-8. PubMed ID: 1316233 [TBL] [Abstract][Full Text] [Related]
2. Low incidence of point mutations detected in the p53 tumor suppressor gene from chemically induced rat renal mesenchymal tumors. Weghorst CM; Dragnev KH; Buzard GS; Thorne KL; Vandeborne GF; Vincent KA; Rice JM Cancer Res; 1994 Jan; 54(1):215-9. PubMed ID: 8261441 [TBL] [Abstract][Full Text] [Related]
3. Mutations of p53 in Wilms' tumors. Takeuchi S; Bartram CR; Ludwig R; Royer-Pokora B; Schneider S; Imamura J; Koeffler HP Mod Pathol; 1995 Jun; 8(5):483-7. PubMed ID: 7675765 [TBL] [Abstract][Full Text] [Related]
4. Genetic analysis of human esophageal tumors from two high incidence geographic areas: frequent p53 base substitutions and absence of ras mutations. Hollstein MC; Peri L; Mandard AM; Welsh JA; Montesano R; Metcalf RA; Bak M; Harris CC Cancer Res; 1991 Aug; 51(15):4102-6. PubMed ID: 1855226 [TBL] [Abstract][Full Text] [Related]
5. Mutational activation of the cellular Harvey ras oncogene in rat esophageal papillomas induced by methylbenzylnitrosamine. Wang Y; You M; Reynolds SH; Stoner GD; Anderson MW Cancer Res; 1990 Mar; 50(5):1591-5. PubMed ID: 2406014 [TBL] [Abstract][Full Text] [Related]
6. p53 tumor suppressor gene mutation in early esophageal precancerous lesions and carcinoma among high-risk populations in Henan, China. Gao H; Wang LD; Zhou Q; Hong JY; Huang TY; Yang CS Cancer Res; 1994 Aug; 54(16):4342-6. PubMed ID: 8044781 [TBL] [Abstract][Full Text] [Related]
7. Polymerase chain reaction-single-strand conformation polymorphism analysis for the VHL gene in chemically induced kidney tumors of rats using intron-derived primers. Shiao YH; Diwan BA; Perantoni AO; Calvert RJ; Zbar B; Lerman MI; Rice JM Mol Carcinog; 1997 Aug; 19(4):230-5. PubMed ID: 9290699 [TBL] [Abstract][Full Text] [Related]
8. Mutations of the p53 tumor suppressor gene occur infrequently in Wilms' tumor. Malkin D; Sexsmith E; Yeger H; Williams BR; Coppes MJ Cancer Res; 1994 Apr; 54(8):2077-9. PubMed ID: 8174107 [TBL] [Abstract][Full Text] [Related]
9. p53 gene mutations in SKH-1 mouse tumors differentially induced by UVB and combined subcarcinogenic benzo[a]pyrene and UVA. Wang Y; Zhou X; Weinstein E; Maryles B; Zhang Y; Moore J; Gao D; Atencio DP; Rosenstein BS; Lebwohl M; Chen HD; Xiao T; Wei H Photochem Photobiol; 2008; 84(2):444-9. PubMed ID: 18248503 [TBL] [Abstract][Full Text] [Related]
10. Mutability of p53 hotspot codons to benzo(a)pyrene diol epoxide (BPDE) and the frequency of p53 mutations in nontumorous human lung. Hussain SP; Amstad P; Raja K; Sawyer M; Hofseth L; Shields PG; Hewer A; Phillips DH; Ryberg D; Haugen A; Harris CC Cancer Res; 2001 Sep; 61(17):6350-5. PubMed ID: 11522624 [TBL] [Abstract][Full Text] [Related]
11. Incidence of p53 and ras gene mutations in DMBA-induced rat leukemias. Wei S; Kito K; Miyoshi A; Matsumoto S; Kauzi A; Aramoto T; Abe Y; Ueda N J Exp Clin Cancer Res; 2002 Sep; 21(3):389-96. PubMed ID: 12385583 [TBL] [Abstract][Full Text] [Related]
12. Sites and types of p53 mutations in an unselected series of colorectal cancers in The Netherlands. Van Den Broek MH; Renault B; Fodde R; Verspaget H; Griffioen G; Khan PM Anticancer Res; 1993; 13(3):587-92. PubMed ID: 8317886 [TBL] [Abstract][Full Text] [Related]
13. Mutations in the tumor suppressor gene p53 in human liver cancer induced by alpha-particles. Andersson M; Jönsson M; Nielsen LL; Vyberg M; Visfeldt J; Storm HH; Wallin H Cancer Epidemiol Biomarkers Prev; 1995; 4(7):765-70. PubMed ID: 8672994 [TBL] [Abstract][Full Text] [Related]
14. Nephroblastoma and renal mesenchymal tumor induced in rats by N-nitrosoethyl- and N-nitrosomethylurea. Turusov VS; Alexandrov VA; Timoshenko IV Neoplasma; 1980; 27(3):229-35. PubMed ID: 6256671 [TBL] [Abstract][Full Text] [Related]
15. A rodent model for Wilms tumors: embryonal kidney neoplasms induced by N-nitroso-N'-methylurea. Sharma PM; Bowman M; Yu BF; Sukumar S Proc Natl Acad Sci U S A; 1994 Oct; 91(21):9931-5. PubMed ID: 7937920 [TBL] [Abstract][Full Text] [Related]
16. Evidence for a gene on 17p13.3, distal to TP53, as a target for allele loss in breast tumors without p53 mutations. Cornelis RS; van Vliet M; Vos CB; Cleton-Jansen AM; van de Vijver MJ; Peterse JL; Khan PM; Børresen AL; Cornelisse CJ; Devilee P Cancer Res; 1994 Aug; 54(15):4200-6. PubMed ID: 8033152 [TBL] [Abstract][Full Text] [Related]
17. Aflatoxin B1-induced rat hepatic hyperplastic nodules do not exhibit a site-specific mutation within the p53 gene. Hulla JE; Chen ZY; Eaton DL Cancer Res; 1993 Jan; 53(1):9-11. PubMed ID: 8380129 [TBL] [Abstract][Full Text] [Related]
18. Mutations of the p53 gene and p53 protein overexpression are associated with sarcomatoid transformation in renal cell carcinomas. Oda H; Nakatsuru Y; Ishikawa T Cancer Res; 1995 Feb; 55(3):658-62. PubMed ID: 7834636 [TBL] [Abstract][Full Text] [Related]
19. Comparison of mutations in the p53 and K-ras genes in lung carcinomas from smoking and nonsmoking women. Gealy R; Zhang L; Siegfried JM; Luketich JD; Keohavong P Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 1):297-302. PubMed ID: 10207632 [TBL] [Abstract][Full Text] [Related]
20. p53 mutation and protein accumulation during multistage human esophageal carcinogenesis. Bennett WP; Hollstein MC; Metcalf RA; Welsh JA; He A; Zhu SM; Kusters I; Resau JH; Trump BF; Lane DP Cancer Res; 1992 Nov; 52(21):6092-7. PubMed ID: 1394236 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]